To quote you, so there is no doubt………
“MSB has in fact on more than one occasion approached the FDA and been granted approval to make changes to the protocols or end points.”
That one sentence was taken from your reply to @stockrock. I may be cynical but you could quite easily have addressed that sentence to @DocMcstuffins in response to the same argument.
In other words, it is more likely probable that MSB did exactly that and therefore The Doc had no argument as previous history likely refutes his argument. But then again, why would you as it doesn’t suit either of your agendas?
Both of you are so transparent.
Ann: 36-Month Results of Phase 3 Trial in Chronic Low Back Pain, page-158
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |